Under de kliniske afprøvninger var der, baseret på den kliniske respons, ingen indikation for udvikling af neutraliserende antistoffer for epoetin- delta hos mennesker.
22 During the clinical trials, there were no indications of development of neutralising antibodies to epoetin delta in humans based on the clinical response.